Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_assertion type Assertion NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_head.
- NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_assertion wasGeneratedBy ECO_0000203 NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_provenance.
- NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_assertion wasDerivedFrom befree-2016 NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_provenance.
- NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_assertion SIO_000772 23384775 NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_provenance.
- NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_assertion evidence source_evidence_literature NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_provenance.
- NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_assertion description "[Frequent outlier kinases in breast cancer included therapeutic targets like ERBB2 and FGFR4, distinct from MET, AKT2, and PLK2 in pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1050563.RAnQ0koCdOdaA4N6kGWT1h3q7DeHDQ10kBH9Iayb32ZRU130_provenance.